These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24055345)

  • 1. PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.
    Jung HY; Jun S; Lee M; Kim HC; Wang X; Ji H; McCrea PD; Park JI
    Mol Cell; 2013 Oct; 52(2):193-205. PubMed ID: 24055345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAF makes it EZ(H2) for β-catenin transactivation.
    Zhang X; He X
    Mol Cell; 2013 Oct; 52(2):157-8. PubMed ID: 24210173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway.
    Amado NG; Predes D; Fonseca BF; Cerqueira DM; Reis AH; Dudenhoeffer AC; Borges HL; Mendes FA; Abreu JG
    J Biol Chem; 2014 Dec; 289(51):35456-67. PubMed ID: 25359775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
    Jung YS; Jun S; Lee SH; Sharma A; Park JI
    Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
    Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
    Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.
    Roy BC; Subramaniam D; Ahmed I; Jala VR; Hester CM; Greiner KA; Haribabu B; Anant S; Umar S
    Oncogene; 2015 Aug; 34(34):4519-30. PubMed ID: 25486432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer.
    Huang S; Fantini D; Merrill BJ; Bagchi S; Guzman G; Raychaudhuri P
    Cancer Res; 2017 Dec; 77(23):6562-6575. PubMed ID: 29021137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
    FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
    Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
    J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRC2 Is Dispensable
    Ferguson J; Devarajan M; DiNuoscio G; Saiakhova A; Liu CF; Lefebvre V; Scacheri PC; Atit RP
    G3 (Bethesda); 2018 Feb; 8(2):491-503. PubMed ID: 29223978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
    Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
    Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esculetin suppresses proliferation of human colon cancer cells by directly targeting β-catenin.
    Lee SY; Lim TG; Chen H; Jung SK; Lee HJ; Lee MH; Kim DJ; Shin A; Lee KW; Bode AM; Surh YJ; Dong Z
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1356-64. PubMed ID: 24104353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
    Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
    Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
    Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
    Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.